DexCom, Inc. DXCM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.18% | 13.08% | 15.05% | 13.12% | 21.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.18% | 13.08% | 15.05% | 13.12% | 21.64% |
| Cost of Revenue | 0.46% | 2.16% | -1.21% | 2.01% | 19.36% |
| Gross Profit | 18.18% | 20.50% | 27.39% | 20.88% | 23.17% |
| SG&A Expenses | 13.34% | 9.36% | 12.77% | -1.80% | 8.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.22% | 4.83% | 3.80% | 1.30% | 14.79% |
| Operating Income | 34.93% | 49.72% | 90.95% | 70.99% | 59.54% |
| Income Before Tax | -5.00% | 31.69% | 74.66% | 61.24% | 98.59% |
| Income Tax Expenses | -12.99% | 11.58% | 43.15% | 23.15% | 60.05% |
| Earnings from Continuing Operations | -3.07% | 38.54% | 89.28% | 76.20% | 110.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.07% | 38.54% | 89.28% | 76.20% | 110.85% |
| EBIT | 34.93% | 49.72% | 90.95% | 70.99% | 59.54% |
| EBITDA | 31.23% | 40.24% | 66.44% | 57.36% | 47.66% |
| EPS Basic | 1.19% | 42.13% | 92.21% | 77.96% | 112.47% |
| Normalized Basic EPS | 29.60% | 39.15% | 72.68% | 62.88% | 53.15% |
| EPS Diluted | 2.56% | 43.63% | 92.21% | 77.97% | 109.87% |
| Normalized Diluted EPS | 31.89% | 41.89% | 76.02% | 64.40% | 53.02% |
| Average Basic Shares Outstanding | -4.19% | -2.52% | -1.53% | -1.00% | -0.79% |
| Average Diluted Shares Outstanding | -5.87% | -4.43% | -3.41% | -1.92% | -0.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |